Historical Valuation
PainReform Ltd (PRFX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.95. The fair price of PainReform Ltd (PRFX) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.85
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
PainReform Ltd (PRFX) has a current Price-to-Book (P/B) ratio of 0.17. Compared to its 3-year average P/B ratio of 1.01 , the current P/B ratio is approximately -83.46% higher. Relative to its 5-year average P/B ratio of 1.05, the current P/B ratio is about -84.18% higher. PainReform Ltd (PRFX) has a Forward Free Cash Flow (FCF) yield of approximately -423.60%. Compared to its 3-year average FCF yield of -379.92%, the current FCF yield is approximately 11.50% lower. Relative to its 5-year average FCF yield of -243.48% , the current FCF yield is about 73.98% lower.
P/B
Median3y
1.01
Median5y
1.05
FCF Yield
Median3y
-379.92
Median5y
-243.48
Competitors Valuation Multiple
AI Analysis for PRFX
The average P/S ratio for PRFX competitors is 0.00, providing a benchmark for relative valuation. PainReform Ltd Corp (PRFX.O) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PRFX
1Y
3Y
5Y
Market capitalization of PRFX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PRFX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PRFX currently overvalued or undervalued?
PainReform Ltd (PRFX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.95. The fair price of PainReform Ltd (PRFX) is between to according to relative valuation methord.
What is PainReform Ltd (PRFX) fair value?
PRFX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of PainReform Ltd (PRFX) is between to according to relative valuation methord.
How does PRFX's valuation metrics compare to the industry average?
The average P/S ratio for PRFX's competitors is 0.00, providing a benchmark for relative valuation. PainReform Ltd Corp (PRFX) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for PainReform Ltd (PRFX) as of Jan 09 2026?
As of Jan 09 2026, PainReform Ltd (PRFX) has a P/B ratio of 0.17. This indicates that the market values PRFX at 0.17 times its book value.
What is the current FCF Yield for PainReform Ltd (PRFX) as of Jan 09 2026?
As of Jan 09 2026, PainReform Ltd (PRFX) has a FCF Yield of -423.60%. This means that for every dollar of PainReform Ltd’s market capitalization, the company generates -423.60 cents in free cash flow.
What is the current Forward P/E ratio for PainReform Ltd (PRFX) as of Jan 09 2026?
As of Jan 09 2026, PainReform Ltd (PRFX) has a Forward P/E ratio of -0.01. This means the market is willing to pay $-0.01 for every dollar of PainReform Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for PainReform Ltd (PRFX) as of Jan 09 2026?
As of Jan 09 2026, PainReform Ltd (PRFX) has a Forward P/S ratio of 0.00. This means the market is valuing PRFX at $0.00 for every dollar of expected revenue over the next 12 months.